Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-21 Option Award |
2025-01-23 5:03 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. SVP, CFO |
78,741 | $0 | 157,482 (Direct) |
View |
| 2025-01-13 Option Award |
2025-01-14 6:50 pm |
N/A 2035-01-12 |
Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. SVP, CFO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 9:00 pm |
N/A 2034-01-03 |
Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. SVP, CFO |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-02 |
Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. SVP, CFO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:15 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. SVP, Chief Financial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-01 8:32 pm |
N/A 2031-09-01 |
Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |